SALT POINT STRATEGIES

Lobbying for VERTEX PHARMACEUTICALS · Biopharmaceutical company.

Filing 1st Quarter - Termination

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 17, 2026

Income

$10,000.00

What the client paid this registrant for the period.

Client based in

Massachusetts

Representation ended

Jan 31, 2026

The registrant reported terminating its work for this client.

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Pharmacy

Non-opioid pain relief and drug pipeline issues.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.